FAST, GD, UNH, TXRH and DGX are five stocks that combine long records of uninterrupted payouts with stable earnings and solid cash flow.

UnitedHealth’s $5 billion buyback announcement signals that the healthcare giant’s turnaround is gaining momentum, making it a lucrative opportunity.

Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.

The stock is trading near 52-week highs, but under the surface, commercial segment cost trends are creating headwinds.

Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Truist, Oppenheimer and KeyBanc moved to $500 targets, with Oppenheimer saying UnitedHealth “handily” beat expectations.

UnitedHealth Group (UNH) beat Wall Street's numbers on July 16, 2026, but its chief financial officer spent the earnings call making sure nobody mistook that result for a solved cost problem. The company beat earnings estimates by roughly 30%, and management raised full-year guidance well past ...

UnitedHealth Group stock has delivered a 54.8% return over the past year, yet the broader valuation checks point to a mixed picture rather than a straightforward bargain or clear overvaluation. UnitedHealth Group's 54.8% gain over the last 12 months puts recent buyers in a strong position, but it also raises the bar for what counts as good value from here. On the positive side, recent earnings strength and margin improvements can support the case that the current price still reflects...

Losing nearly one million Medicare Advantage members would normally be enough to send investors running. Not this time. Buried in UnitedHealth Group Inc’s second-quarter earnings report Thursday morning was a striking statistic: the company has lost 965,000 Medicare Advantage members...

The sticker price on CVS shares looks high, but the real question is what it costs on the earnings expected two years from now.

The health insurer raised its forecast after a solid quarter, but investors focused on the one business so broken it’s forcing a strategic retreat.

Jim Cramer named five blue-chip stocks the market punished after strong earnings, and he's betting that millions of investors and billions of dollars got it completely wrong.

Check out the companies making headlines this week:

The FDA just approved the first once-daily oral PCSK9 pill, and five major stocks now sit in the crosshairs. Not all of them come out ahead, and the biggest surprise winner may not be the company that makes the drug.

UnitedHealth Group's (UNH) Medicare Advantage business should continue to drive positive growth desp

UNH lifts its 2026 outlook as Medicare and Optum improve, while commercial cost pressures delay margin recovery and keep management focused on execution.

Wall Street closed lower on Thursday, dragged down by technology stocks, as investors assessed second-quarter earnings and a batch of economic data.

(Bloomberg) -- Circle Internet Group Inc. shares have lost more than three-quarters of their value from the highs seen just after their initial public offering last year and as more stablecoins come to market, one analyst is warning it could get worse.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsGoogle Gemini Launch Delayed as Tech Falls Short of Internal GoalsBeckham’s IM8 Gets $1 Billion From General Catalyst for GrowthCIA Says AI Drones Give Russian T

The company doubled its 2026 buyback target to at least $5 billion after already repurchasing $4 billion of shares.

Apple, AtaiBeckley and UnitedHealth Group jumped to yearly highs as positive company catalysts, Wall Street upgrades, and strong earnings pushed shares higher.

CEO Hemsley reports 55% operating earnings growth and raises full-year guidance.

UnitedHealth Group Incorporated will release earnings for its second quarter before the opening bell on Thursday, July 16. Analysts expect the company to report quarterly earnings of $4.85 per share, up from $4.08 per share in the year-ago period. The...

TSMC’s higher spending outlook raised concerns about near-term margins and returns in the ongoing AI infrastructure buildout.

Citi analysts laid out the appeal of biopharma stocks, with the NYSE Arca Pharmaceutical Index outrunning the S&P in the last month.

U.S. stocks fell, with the Nasdaq composite ending 1.5% lower, as a fresh wave of selling hit semiconductor stocks.

(Updates with closing levels throughout the story.) Wall Street's stock indexes fell Thursday aft

Shares of health insurance company UnitedHealth (NYSE:UNH) jumped 5.1% in the morning session after the company reported second-quarter earnings that surpassed Wall Street's expectations, driven by improved profitability.

(Updates with index/price moves, macroeconomic data, and geopolitical news from the first paragraph.

Broad Market Indicators Broad-market exchange-traded fund IWM edged higher and IVV fell. Activ

(Updates with index/price moves and company/geopolitical news from the first paragraph.) US equit

UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.

Q2 earnings are off to a strong start. Tech, Energy, Materials, Finance and Aerospace ETFs could shine as profit growth broadens across sectors.

The S&P 500 and Nasdaq Composite were down in late-morning trading Thursday, while the Dow Jones Ind

Retail Sales Come in Better-Than-Expected

UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares climbed about 5% in post-market trading after the healthcare company reported second quarter results that beat Wall Street expectations and raised its full-year adjusted earnings outlook. For the quarter ended June 30, UnitedHealth reported...

The stock is still 25% off all-time highs.

Retail Sales cool as expected, Jobless Claims improve and Philly Fed shoots up 4x estimates.

AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.

UnitedHealth Group (NYSE:UNH) reported sharply higher second-quarter 2026 earnings and raised its full-year outlook, citing improved performance in Medicare Advantage and Optum Health, while cautioning that commercial medical cost trends remain elevated and are delaying margin recovery in that busin

Magellan Investment Partners, an Australian investment management company, released its second-quarter 2026 investor letter for “Magellan Global Opportunities Fund”. A copy of the letter can be downloaded here. The Fund invests in companies with sustainable competitive advantages that generate returns exceeding their cost of capital over time. In Q2, the global stock market rose 13.8%, […]

While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.

UnitedHealth (UNH) raised its full-year earnings outlook on Thursday as the health insurance giant r

The core narrative surrounding UnitedHealth Group (UNH) is dominated by its successful margin recovery, yet the underlying data reveal a shift from a growth compounder to a vulnerable margin defender. The defining insight is not the massive bottom-line beat of a $6.38 adjusted earnings per share against a $4.94 consensus estimate. Rather, it is the deliberate contraction of the core membership base to support margins in the face of significant regulatory headwinds.

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3%, and the actively t

(Updates with economic data, recent oil price movement, world markets' overview and corporate stock

Investing.com -- U.S. stock index futures were mixed on Thursday as investors weighed lingering Middle East tensions, and focused on corporate earnings and further signs that U.S. inflationary pressures are easing.

Stock Market Today: Tech futures tumbled Thursday as Sandisk and SK Hynix plunged. TSMC sold off on earnings.

Dow Jones futures: Taiwan Semiconductor and GE Aero fell despite strong earnings as the AI stock sell-off continues.